Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 4, 2024 12:21 PM 6 min read

Salesforce Analysts Raise Forecasts After Q3 Earnings: 'Leading The Way In Agentic AI Cycle'

by Priya Nigam Benzinga Staff Writer
Follow

Salesforce Inc (NYSE:CRM) shares were climbing in on Wednesday, despite the company reporting an earnings miss in the third quarter.

The company reported its results amid an exciting earnings season. Here are some key analyst takeaways.

Stifel On Salesforce

Analyst J. Parker Lane reiterated a Buy rating while raising the price target from $390 to $425.

Salesforce reported current RPOs (remaining performance obligations) of $26.4 billion, representing 10% year-on-year growth and beating consensus estimate of $26.1 billion, Lane said in a note. The company's cRPO growth remains in double-digits for the second consecutive quarter, despite Agentforce and Data Cloud not contributing meaningfully as of now, he added.

"With the story now centered around the Agentforce/AI opportunity, we believe management’s disclosure of 200 Agentforce deals (GA late in the quarter) and a significant pipeline served as solid initial proof-points in the company’s ability to capture AI workloads and its positioning relative to enterprise competitors," the analyst wrote.

Salesforce is "the best way to play AI within our coverage universe," he further stated.

RBC Capital Markets On Salesforce

Analyst Rishi Jaluria maintained an Outperform rating while lifting the price target from $300 to $420.

Salesforce's third-quarter results were "solid," sending shares higher by 11% in the after-hours session on Tuesday, Jaluria said. "Subscription revenue growth stabilized, and cRPO growth was solid, remaining in double-digits," he added.

The company raised the midpoint of its fourth-quarter guidance for total revenue by around $50 million, while stating that its acquisition of Own closed at the end of the quarter, the analyst stated. "While Agentforce updates were encouraging, we question if expectations are getting ahead of NTM (next twelve months) reality," he further wrote.

JPMorgan On Salesforce

Analyst Mark Murphy reaffirmed an Overweight rating while raising the price target from $340 to $380.

Salesforce's earnings slightly missed expectations due to strategic investments, Murphy said. Total revenue came in at $9,444 million, beating Street estimates of $9,351 million, he added.

Although the company's fourth-quarter revenue guidance came in below consensus, this was "overshadowed by successful attainment or slight upside across other metrics" in the third quarter, including cRPO, margins, and cash flows, the analyst stated.

Salesforce was expected to be "ultra-bullish" about Agentforce during its earnings call and the company "actually surpassed that expectation," he further wrote.

BMO Capital Markets On Salesforce

Analyst Keith Bachman reiterated an Outperform rating while lifting the price target from $385 to $425.

Salesforce delivered strong quarterly results and guided to cRPO in-line with estimates, Bachman said. The company closed 200 paying Agentforce deals post general availability (GA) in the last week of the quarter, he added.

"In addition, management stated that 25% of the F100 have adopted Data Cloud, though we believe a very small percent of Salesforce installed base has adopted to date," the analyst wrote. He stated, however, that the adoption of Data Cloud could be "a source of friction" in the adoption of Agentforce.

Check out other analyst stock ratings.

Oppenheimer On Salesforce

Analyst Brian Schwartz maintained an Outperform rating while raising the price target from $385 to $415.

Salesforce achieved operating margins of 33.1%, higher than the consensus by 80 basis points (bps), Schwartz said. Pro forma earnings of $2.41 per share came in three cents below the consensus, driven by strategic investments, excluding which the figure would have come in at $2.59 per share, he added.

This was another quarter of double-digit cRPO billings growth and "this positive trend looks durable," as software spending trends are likely to normalize as macro uncertainties ease and the "rising importance of IT and AI in driving growth and efficiencies with the enterprise," the analyst wrote.

"This development positions CRM to reaccelerate top-line revenue growth, as soon as F2Q:26," he further stated.

Needham On Salesforce

Analyst Scott Berg reaffirmed a Buy rating while lifting the price target from $345 to $375.

Salesforce reported total revenue growth of 8.3% year-on-year, with subscription revenue growth of 9.1%, "driven by resilience in core Clouds," Berg said. Professional services revenue contracted by 2.4%, but came in above expectations, he added.

"While not a material contributor to financial results yet, Salesforce noted that the company closed over 200 Agentforce deals during 3Q in the one week the product was available during the quarter, with notable brands utilizing it already," the analyst wrote.

Management raised its revenue guidance for the full year to a range of $37.8 billion to $38.0 billion, from its prior projection of $37.7 billion to $38.0 billion, he added.

Piper Sandler On Salesforce

Analyst Brent Bracelin reiterated an Overweight rating while raising the price target from $325 to $395.

Salesforce's revenue growth slowed to 7%-8% on "more of the same" challenges that it faced through the year, including "macro pressures, internal budgetary battles, AI experimentation and evaluation, and longer sales cycles," Bracelin said.

"F2026 is shaping up to be an important transitional year for CRM as it executes on laying the groundwork to bring AI agents to the enterprise masses with new pricing and packaging offerings (Agentforce, Foundations, Data Cloud, etc.) that could better position the company for a F2027 rebound," the analyst wrote.

There is downside risk to the current consensus estimate for revenue growth of 9% for that year, he added.

BofA Securities On Salesforce

Analyst Brad Sills maintained a Buy rating while raising the price target from $390 to $440.

The third-quarter results suggest that Salesforce is "leading the way in agentic AI cycle with Agentforce," Sills said. Management pipeline commentary indicated "meaningful customer interest" in the weeks after the tool's release in October, he added.

The company raised its full-year margin guidance by 10 basis points, which indicates that "this emerging product cycle is not derailing margin expansion," the analyst stated. "Ongoing acceleration in the core from agents and multi-cloud strength is likely to more than offset softness in non-core businesses," he further wrote.

Guggenheim Securities On Salesforce

Analyst John DiFucci maintained a Neutral rating on the stock.

Salesforce exceeded consensus estimates, including cRPO, "which benefited from early renewals more than from strong new bookings," DiFucci said. The company's fourth-quarter guidance came in below the Street, "despite getting about 1% of growth from acquisitions completed in November," he added.

Street expectations of 9% revenue growth in fiscal 2026 appears "optimistic," unless the company makes more acquisitions, the analyst stated.

CRM Price Action: Shares of Salesforce had risen by 8.19% to $358.01 at the time of publication on Wednesday.

Read More:
• Salesforce Q3 Earnings Preview: Analyst Says ‘Transitional Year’ Coming, Recommends To Add Shares On Pullbacks

Photo: Photo Gonzo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEarningsEarnings BeatsPrice TargetReiterationTop StoriesAnalyst RatingsMoversTechTrading IdeasAIartificial intelligenceBMO Capital MarketsBofA SecuritiesBrad SillsBrent BracelinBrian SchwartzExpert IdeasGuggenheim SecuritiesJPMorganKeith BachmanMark MurphyNeedhamOppenheimerPiper SandlerRBC Capital MarketsRishi JaluriaScott BergStifelStories That Matter
CRM Logo
CRMSalesforce Inc
$189.800.04%
Overview
CRM Logo
CRMSalesforce Inc
$189.800.04%
Overview
Comments
Loading...